280556-71-0 Usage
General Description
(4-Morpholin-4-yl-phenyl)methanol is a chemical compound with the molecular formula C12H15NO2. It is a white crystalline solid with a molecular weight of 205.25 g/mol. (4-MORPHOLIN-4-YL-PHENYL)METHANOL is a member of the morpholine family and contains a phenyl ring with a morpholine group attached. It is commonly used as a building block in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. This chemical is also known for its applications in drug discovery and development, particularly in the design and synthesis of potential therapeutic agents. Additionally, it has been studied for its potential pharmacological properties and its role as a versatile intermediate in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 280556-71-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,0,5,5 and 6 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 280556-71:
(8*2)+(7*8)+(6*0)+(5*5)+(4*5)+(3*6)+(2*7)+(1*1)=150
150 % 10 = 0
So 280556-71-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO2/c13-9-10-1-3-11(4-2-10)12-5-7-14-8-6-12/h1-4,13H,5-9H2
280556-71-0Relevant articles and documents
Hydrogenation of Esters by Manganese Catalysts
Li, Fu,Li, Xiao-Gen,Xiao, Li-Jun,Xie, Jian-Hua,Xu, Yue,Zhou, Qi-Lin
, (2022/01/13)
The hydrogenation of esters catalyzed by a manganese complex of phosphine-aminopyridine ligand was developed. Using this protocol, a variety of (hetero)aromatic and aliphatic carboxylates including biomass-derived esters and lactones were hydrogenated to primary alcohols with 63–98% yields. The manganese catalyst was found to be active for the hydrogenation of methyl benzoate, providing benzyl alcohol with turnover numbers (TON) as high as 45,000. Investigation of catalyst intermediates indicated that the amido manganese complex was the active catalyst species for the reaction. (Figure presented.).
Antithrombotic amides
-
, (2008/06/13)
This application relates to a compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermidates thereof.